Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Bedrosian Camille L
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-01
Sale
2022-03-03
6:07 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
2,821$66.62$187,93572,838
(Direct)
View
2022-01-30
Sale
2022-02-01
1:39 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
1,657$66.3$109,85936,759
(Direct)
View
2021-10-14
Sale
2021-10-18
7:02 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
359$81.14$29,12938,416
(Direct)
View
2021-09-01
Sale
2021-09-02
6:11 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
5,000$100.11$500,525147,275
(Direct)
View
2021-05-06
Sale
2021-05-10
6:09 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
364$113.67$41,37638,775
(Direct)
View
2021-04-15
Sale
2021-04-19
5:17 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
5,000$109.09$545,45097,139
(Direct)
View
2021-03-01
Sale
2021-03-03
8:37 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
4,543$138.18$627,75250,139
(Direct)
View
2021-01-30
Sale
2021-02-02
4:28 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
2,243$140.36$314,82733,546
(Direct)
View
2021-01-15
Sale
2021-01-19
4:01 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
25,000$139.18$3,479,50098,789
(Direct)
View
2020-10-14
Sale
2020-10-16
7:22 pm
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
262$88$23,05635,789
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-17
Option Award
2022-06-21
4:44 pm
N/A
2032-06-16
Crinetics Pharmaceuticals Inc.CRNXBedrosian Camille L
Director
17,500$017,500
(Direct)
View
2022-06-08
Option Award
2022-06-10
4:09 pm
N/A
2032-06-07
RHYTHM PHARMACEUTICALS IncRYTMBedrosian Camille L
Director
20,000$020,000
(Direct)
View
2022-03-01
Option Award
2022-03-03
6:07 pm
N/A
2032-03-01
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
38,900$072,838
(Direct)
View
2021-09-01
Exercise
2021-09-02
6:11 pm
N/A
2028-01-30
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
5,000$0147,275
(Direct)
View
2021-09-01
Exercise
2021-09-02
6:11 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
5,000$55147,275
(Direct)
View
2021-06-22
Option Award
2021-06-23
5:00 pm
N/A
2031-06-21
Crinetics Pharmaceuticals Inc.CRNXBedrosian Camille L
Director
17,500$017,500
(Direct)
View
2021-06-09
Option Award
2021-06-11
4:05 pm
N/A
2031-06-08
RHYTHM PHARMACEUTICALS IncRYTMBedrosian Camille L
Director
15,000$015,000
(Direct)
View
2021-04-15
Exercise
2021-04-19
5:17 pm
N/A
2028-01-30
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
5,000$097,139
(Direct)
View
2021-04-15
Exercise
2021-04-19
5:17 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
5,000$5597,139
(Direct)
View
2021-03-01
Option Award
2021-03-03
8:37 pm
N/A
2031-03-01
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
21,136$050,139
(Direct)
View
2021-01-15
Exercise
2021-01-19
4:01 pm
N/A
2028-01-30
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
25,000$098,789
(Direct)
View
2021-01-15
Exercise
2021-01-19
4:01 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
25,000$5598,789
(Direct)
View
2020-12-09
Option Award
2020-12-11
4:11 pm
N/A
2030-12-08
RHYTHM PHARMACEUTICALS IncRYTMBedrosian Camille L
Director
37,000$037,000
(Direct)
View
2020-09-01
Option Award
2020-09-03
5:58 pm
N/A
2030-08-31
Crinetics Pharmaceuticals Inc.CRNXBedrosian Camille L
Director
25,000$025,000
(Direct)
View
2020-05-06
Tax Withholding
2020-05-08
8:12 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
249$66.2636,051
(Direct)
View
2020-03-01
Option Award
2020-03-03
7:45 pm
N/A
2030-03-01
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
33,934$057,300
(Direct)
View
2020-03-01
Tax Withholding
2020-03-03
7:45 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
1,249$56.0857,300
(Direct)
View
2020-01-30
Tax Withholding
2020-01-31
1:58 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
1,624$53.2324,615
(Direct)
View
2019-10-14
Option Award
2019-10-16
7:24 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
1,437$026,239
(Direct)
View
2019-05-06
Option Award
2019-05-07
6:55 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
1,438$024,802
(Direct)
View
2019-03-01
Option Award
2019-03-04
5:09 pm
N/A
2029-03-01
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
28,500$044,864
(Direct)
View
2019-01-30
Tax Withholding
2019-02-15
5:49 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREBedrosian Camille L
EVP and Chief Medical Officer
1,636$48.8516,364
(Direct)
View